Stay updated with breaking news from Pharma Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research report report published on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. CTIC has been the topic of a number of other research reports. Stifel Nicolaus cut CTI BioPharma from a buy rating to a hold […]
StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research note released on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently commented on CTIC. Stifel Nicolaus cut shares of CTI BioPharma from a buy rating to […]
Latest Study on Industrial Growth of Genome Perturbation Tools Market 2023-2029. A detailed study accumulated to offer Latest insights about acute fea
CTI BioPharma (NASDAQ: CTIC) recently received a number of ratings updates from brokerages and research firms: 5/26/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/18/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/16/2023 […]
CHICAGO — Fewer than half of adolescents and young adults with acute lymphoblastic leukemia received first-line treatment at a specialized cancer center, despite an association of such treatment with longer survival, study results showed.The findings, presented at ASCO Annual Meeting, also revealed independent associations of age, race/ethnicity and insurance type with odds of treatment at